Daisuke Yabe

Has grant

Director and Professor

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Daisuke Yabe is the Director and Professor at Gifu University Institute for Advanced Study in Japan. His research focuses on diabetes management, cardiovascular implications of diabetes therapies, and the application of nutritional guidance and exercise therapy for metabolic disorders. Recent articles highlight his contributions to understanding diabetes complications, the effects of glucagon-like peptide-1 receptor agonists, and innovative treatment strategies for type 2 diabetes.

Recent Grants

Grant: Close

Establishment of an experimental system to evaluate pancreatic beta-cell proliferation in vitro that can be utilized to identify anti-diabetes therapeutics targeting pancreatic beta-cell mass

Open Date: 2021-04-01

Close Date: 2022-03-01

Grant: Close

Identification of ChREBP-mediated Acetate Metabolism

Open Date: 2020-04-01

Close Date: 2023-03-31

Grant: Close

糖尿病性腎症重症化予防プログラムの効果検証と重症化予防のさらなる展開を目指した研究

Open Date: 2018-04-01

Close Date: 2020-03-31

Grant: Close

Genetic dissection of rare MODY by multidisciplinary functional genomics

Open Date: 2018-04-01

Close Date: 2021-03-31

Grant: Close

糖尿病性腎症重症化予防プログラムの効果検証と重症化予防のさらなる展開を目指した研究

Open Date: 2018-04-01

Close Date: 2020-03-31

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (21)

Ryo Suzuki

Professor & Chairperson

Tokyo Medical and Dental University

JAPAN

Daisuke Yabe

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

A multicenter, prospective, real‐world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice (PIONEER REAL Japan): Subgroup analyses

Accelerating innovation and ensuring the thoughtful withdrawal of lifeline medicines for people living with diabetes in Asia

Cardiovascular risk reduction with glucagon‐like peptide‐1 receptor agonists is proportional to HbA1c lowering in type 2 diabetes: An updated meta‐regression analysis incorporating FLOW and SOUL trials

Depression risk associated with spouses’ diabetes and cardiovascular events: a nationwide cohort study

Heterogeneous cardiovascular effects of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes: a causal forest and target trial emulation study

Improvement of Symptoms in a Patient With Glycogen Storage Disease Through Nutritional Guidance and Exercise Therapy

Response to commentary on ‘A prediction model for diabetes complications using the Kokuho Database and its application to public health services in Japan’

Insulinoma diagnosis and characterization with intratumoral heterogeneity employing [18F]FB(ePEG12)12-exendin-4 PET/MRI

Correction: Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial

Evolving incretin-based therapies in Japan: optimizing treatment strategies for diverse clinical and socioeconomical profiles in type 2 diabetes

Effectiveness, safety, initial optimal dose, and optimal maintenance dose range of basal insulin regimens for type 2 diabetes: A systematic review with meta‐analysis

Empagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in routine care in East Asia: Results from the EMPRISE study

Impact of the angiotensin receptor‐neprilysin inhibitor in clinical diabetes management: Potential benefits and pitfalls

Efficacy and safety of the sodium‐glucose co‐transporter‐2 inhibitor empagliflozin in elderly Japanese adults (≥65 years) with type 2 diabetes: A randomized, double‐blind, placebo‐controlled, 52‐week clinical trial (EMPA‐ELDERLY)

Effect of Roxadustat on Thyroid Function in Patients With Renal Anemia

Oral Semaglutide under Human Protocols and Doses Regulates Food Intake, Body Weight, and Glycemia in Diet-Induced Obese Mice

Efficacy and Safety of 6-Month High Dietary Protein Intake in Hospitalized Adults Aged 75 or Older at Nutritional Risk: An Exploratory, Randomized, Controlled Study

Use of iGlarLixi for the Management of Type 2 Diabetes in Japanese Clinical Practice: Prior Treatment Subgroup Analysis of the SPARTA Japan Study

Erdheim-Chester Disease With BRAF V600E Mutation and Central Diabetes Insipidus Successfully Treated With Glucocorticoid

Advances in insulin therapy from discovery to β‐cell replacement

Collaborators (21)

Ryo Suzuki

Soo Lim

Dae Jung Kim

Masaomi Nangaku

Motoko Yanagita

Daiji Kawanami

Takaaki Murakami

Satoshi Yoshiji

Atsushi Suzuki

Hiroto Honda

jun xia

Shingo Fukuma

Hiroto Minamino

Yusuke Tsugawa

Kohjiro Ueki

Norio Harada

Hiroki Fujita

Takuya Haraguchi

Atsutaka Yasui

Naoki Kondo

Toshiaki Komura

Make your next move.